273 related articles for article (PubMed ID: 122421)
1. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
3. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
5. Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
Tucker HS; Lankford HV; Gardner DF; Blackard WG
J Clin Endocrinol Metab; 1980 Nov; 51(5):968-71. PubMed ID: 6775003
[TBL] [Abstract][Full Text] [Related]
6. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
Arafah BM; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
[TBL] [Abstract][Full Text] [Related]
8. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
9. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas.
Schlechte J; Vangilder J; Sherman B
J Clin Endocrinol Metab; 1981 Apr; 52(4):785-9. PubMed ID: 7193686
[TBL] [Abstract][Full Text] [Related]
11. Defective regulation of prolactin secretion after successful removal of prolactinomas.
Camanni F; Ghigo E; Ciccarelli E; Massara F; Campagnoli C; Molinatti G; Müller EE
J Clin Endocrinol Metab; 1983 Dec; 57(6):1270-6. PubMed ID: 6415087
[TBL] [Abstract][Full Text] [Related]
12. Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia.
Lankford HV; Blackard WG; Gardner DF; Tucker HS
J Clin Endocrinol Metab; 1981 Jul; 53(1):109-2. PubMed ID: 6787063
[TBL] [Abstract][Full Text] [Related]
13. Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea.
Post KD; Biller BJ; Adelman LS; Molitch ME; Wolpert SM; Reichlin S
JAMA; 1979 Jul; 242(2):158-62. PubMed ID: 448889
[TBL] [Abstract][Full Text] [Related]
14. Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
Casper RF; Rakoff JS; Quigley ME; Gilliland B; Alksne J; Yen SS
Am J Obstet Gynecol; 1980 Feb; 136(4):518-23. PubMed ID: 6766667
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
16. Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
Aono T; Shioji T; Kinugasa T; Onishi T; Kurachi K
J Clin Endocrinol Metab; 1978 Sep; 47(3):675-80. PubMed ID: 122411
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.
Losa M; Mortini P; Barzaghi R; Gioia L; Giovanelli M
J Clin Endocrinol Metab; 2002 Jul; 87(7):3180-6. PubMed ID: 12107221
[TBL] [Abstract][Full Text] [Related]
18. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
[TBL] [Abstract][Full Text] [Related]
19. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
Sowers JR; Carlson HE; Brautbar N; Hershman JM
J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
